How does nomlafobusp help with FA?

José Lopes, PhD avatar

by José Lopes, PhD |

Share this article:

Share article via email
A

How does nomlafobusp help with FA?

Category: CTI-1601

Nomlafobusp is an experimental therapy that is not yet approved for the treatment of Friedreich’s ataxia. It is designed to deliver a functional version of frataxin — a protein whose shortage causes Friedreich’s ataxia — to help improve the functionality of mitochondria, the so-called “powerhouses” of cells. This is expected to help ease FA symptoms.

Print This Page

About the Author

José Lopes, PhD avatar
José Lopes, PhD José holds a PhD in neuroscience from the University of Porto, Portugal. After postdocs at Weill Connell Medicine and Western University, where he studied the processes driving hypertension and Alzheimer’s disease, he moved on in 2016 to a career in science writing and communication. José is the author of several peer-reviewed papers and a book chapter and has presented his research in numerous international meetings.

Recent Posts


Recommended reading